| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BIXT | Common | Gift | -$442K | -3.2M | -12.06% | $0.14 | 23.3M | 19 Nov 2021 | Direct | F1 |
| transaction | BIXT | Common | Award | $2.68K | +1.34M | $0.00* | 1.34M | 03 Dec 2021 | by NDPD Pharma, Inc. |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BIXT | Warrants | Award | $36K | +100K | $0.36 | 100K | 02 May 2021 | Common | 100K | $2.00 | by NDPD Pharma, Inc. | F2 |
| Id | Content |
|---|---|
| F1 | Shares returned to Company's treasury |
| F2 | The warrant agreement includes provisions for dilutive issuance and cash-less exercise |